Andreas Hoel, Biotage 05 July 2005
Synthos 3000 - "Efficient, Powerful and Robust" 02 May 2005
Rene Myers & Robert England, Biotage Biosystems Group 10 October 2004
Brian Warrington, VP Technology Development - Chemistry, GlaxoSmithKline 18 February 2004
Michael J. Collins, President and CEO of CEM 17 September 2003
Dr. C. Oliver Kappe , Karl-Franzens University, Graz 11 August 2003